Inox Clean Energy, a subsidiary of Inox Solar, has commenced production at its new solar module manufacturing facility in Bavla, Ahmedabad,...

Robinsons Global Logistics Solutions has signed a five-year lease with IndoSpace for a 30,000 sq ft sustainable Grade-A warehouse in Bavla,...

This six-lane flyover has been built by the Ahmedabad Urban Development Authority (AUDA) at a cost of Rs 73 crore to ease traffic congestio...

After reporting a drop in revenue and a net loss for FY21, the company is expected to benefit from high potential new molecules that are cu...

The $1.7 billion textile-to-retail conglomerate has set up 2 manufacturing facilities in the region and said a third facility will commence...

On the BSE, 1 lakh shares were traded on the counter so far as against the average daily volumes of 1.49 lakh shares in the past two weeks.

Dishman Pharmaceuticals and Chemicals today said it has received a licence from Johnson & Johnson to manufacture raw material for a tubercu...

Dishman Pharmaceuticals and Chemicals surged 16.22 per cent to close at 306.95. The stock closed at a fresh 52-week high on Wednesday.

Dishman rallied as much as 3% on reports that the company is in talks to sell its 175 hectares of land in Gujarat to Nirma to cut its debt.

Textile maker Pradip Overseas Limited announced its plans to set up an industrial hub spread over 18,00,000 sq. yards at Bavla near Ahmedab...

Ahmedabad-based Dishman group will acquire 100 hectares land and revive its engineering SEZ project, it scrapped two years ago.

The promoters of furnace maker Electrotherm acquired the US battery maker, Firefly Energy, in October 2010 along with its patented technolo...

Jordan-based Hikma Pharmaceuticals is in negotiations to buy 30% stake in Mumbai-based Unimark Remedies, two people familiar with the matte...

Dishman Pharmaceuticals Ltd, will now focus on the high-potency therapies like steroids, hormones, isotopes and cytotoxics.

Drug maker Dishman Pharmaceuticals on Thursday said it will invest Rs 500 crore in two special economic zones and has completed acquisition...

Shares of Dishman Pharmaceuticals & Chemicals surged nearly 10 per cent after it announced plans to invest Rs 5 billion in two SEZs and ent...

Prabhudas Lilladher has reiterated ‘outperformer’ rating on Dishman Pharmaceuticals for a price target of Rs 449 (15x FY10 earnings), an im...